"Heart Failure Pipeline Analysis"DelveInsight's,“Heart Failure - Pipeline Insight, 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Heart Failure pipeline ...

The HF-AI technology aligns perfectly with our mission to transform complex cardiac data into actionable insights that improve patient outcomes.” - Shawn Kumar, CEO of RhythmScienceSAN FRANCISCO, CA, ...

SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...

Belgrade, Serbia – 17 May 2025. An artificial intelligence-enabled electrocardiogram-based algorithm performed well in the early detection of heart failure among healthcare-seeking individuals in ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

Current models of mortality risk after heart failure (HF) rely primarily on cardiac-specific clinical variables and may underestimate risk in elderly East Asian patients. Researchers from Japan used ...

Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to reach $70 billion to $80 billion by 2030), driven by hospitalizations, ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

Juntendo University researchers have trained a machine learning algorithm to use clinical information and physical function ...

‘Gamechanger’ brought in after success of trial offering larger doses of drugs within first two weeks of treatment People in Britain with heart failure are being given larger doses of drugs at the ...

Add Yahoo as a preferred source to see more of our stories on Google. Two UK hospitals were part of a multinational clinical trial of an ’aggressive’ treatment for the potentially fatal condition ...